Latest Biotech News

Blackstone Life Sciences will invest up to $1.5 billion to fund Pfizer’s obesity program centered on berobenatide, a potentially once-monthly GLP-1 candidate the company gained through its $10...

Reuters reports the FDA’s Commissioner’s National Priority Voucher program has effectively been shelved after the program’s lack of new vouchers since former FDA Commissioner Marty Makary left....

Bristol Myers Squibb is consolidating its R&D leadership, combining research and development under Cristian Massacesi while Robert Plenge steps down as chief research officer. The company says the...

Researchers at the University of Pittsburgh report in Science Translational Medicine that nearly all participants in the National Institutes of Health’s All of Us cohort carried at least one...

Two complementary reports focus on clinical AI’s real-world limits. A scoping review finds infection-surveillance AI is still rarely validated or deployed in live healthcare environments, despite...

A study reports that a functionally enhanced subgroup of human retinal progenitor cells integrates into host retina and supports structural preservation and visual functional recovery in retinal...

Preclinical work ties innate immune signaling to pancreatic cancer progression via TREM1-driven neutrophil extracellular trap formation, proposing a prognostic biomarker and therapeutic target....

A prospective analysis using plasma proteomics in UK Biobank maps measurable biological shifts years before clinical age-related macular degeneration diagnosis. Across 45,379 participants followed...

A randomized trial evaluates rapid molecular testing in suspected ventilator-associated pneumonia and finds that targeted therapy is started earlier only when cultures confirm infection, without...

Researchers develop a smartphone-based colorimetric system using silver nanoprisms to detect betaxolol in blood plasma from a single drop. The approach combines portable optics with digital color...

Blackstone Life Sciences agreed to fund up to $1.5 billion tied to Pfizer’s ex-Metsera GLP-1 obesity candidate berobenatide, according to an advance readout summarized in STAT. The co-funding...

Blackstone backing is also framed around Pfizer’s shift toward a monthly obesity-treatment strategy, per a STAT+ readout. The report characterizes the investment as a bet on regimen design—where...

Reuters reports the FDA has shelved the Commissioner’s National Priority Voucher program, while another update highlights the tight Senate committee timeline around Heidi Overton’s nomination to...

Bristol Myers Squibb announced an R&D leadership shakeup that merges research responsibilities under Chief Medical Officer Cristian Massacesi, as Chief research officer Robert Plenge is set to...

A separate summary of the same Bristol Myers transition frames it as an “evolution” of the company’s R&D structure, with Massacesi gaining additional titles and Plenge departing as the research...

Researchers reported that an optimized VH domain-based anti–fibroblast activation protein (FAP) CAR-T design showed enhanced antitumor persistence and improved preclinical safety compared with a...

A real-world retrospective analysis of 178 US patients with Alagille syndrome found that maralixibat treatment enabled 43% to discontinue at least one concomitant medication during long-term...

An updated systematic review and meta-analysis reported that finerenone reduced composite kidney and cardiovascular risks in diabetic kidney disease. The analysis consolidates evidence from prior...

Bold Therapeutics presented details on its GI cancer program BOLD-100 at BIO-Europe 2026, describing progress in a global randomized Phase 2 trial in colorectal, gastric, biliary tract, and...

EnGene provided an update after a prior May setback in its bladder cancer therapy durability data had hurt the company’s stock. The latest reported data looked better than the earlier cut, though...